Amanote Research
Register
Sign In
771. Overcoming Resistance to Antibody Targeted Therapy in Cancer Using Gene-Modified T Cells
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35784-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
ACS Nano
Materials Science
Nanoscience
Engineering
Nanotechnology
Astronomy
Physics
Targeted Photodynamic Therapy of Breast Cancer Cells Using Antibody–phthalocyanine–gold Nanoparticle Conjugates
Photochemical and Photobiological Sciences
Theoretical Chemistry
Physical
Adoptive T-Cell Therapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
International Journal of Hematology
Hematology
Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells
Clinical Cancer Research
Cancer Research
Oncology
Overcoming Resistance to Checkpoint Blockade Therapy by Targeting PI3Kγ in Myeloid Cells
Nature
Multidisciplinary
Targeted T Cells for Anticancer Therapy
Science-Business eXchange
Transcriptionally Targeted Gene Therapy to Detect and Treat Cancer
Trends in Molecular Medicine
Molecular Medicine
Molecular Biology
Functionalized Folate-Modified Graphene Oxide/Pei siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy
Nanoscale Research Letters
Materials Science
Nanotechnology
Condensed Matter Physics
Nanoscience
Transgenerational Transfer of Gene-Modified T Cells
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology